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Estimation of individual treatment effect in observational data is complicated due to the chal-
lenges of confounding and selection bias. A useful inferential framework to address this is the
counterfactual (potential outcomes) model which takes the hypothetical stance of asking what if
an individual had received both treatments. Making use of random forests (RF) within the coun-
terfactual framework we estimate individual treatment effects by directly modeling the response.
We find accurate estimation of individual treatment effects is possible even in complex hetero-
geneous settings but that the type of RF approach plays an important role in accuracy. Methods
designed to be adaptive to confounding, when used in parallel with out-of-sample estimation,
do best. One method found to be especially promising is counterfactual synthetic forests. We
illustrate this new methodology by applying it to a large comparative effectiveness trial, Project
Aware, in order to explore the role drug use plays in sexual risk. The analysis reveals important
connections between risky behavior, drug usage, and sexual risk.
Keywords: Counterfactual Model; Individual Treatment Effect (ITE); Propensity Score; Syn-
thetic forests; Treatment Heterogeneity
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1 Introduction
Even for a medical discipline steeped in a tradition of randomized trials, the evidence basis for
only a few guidelines is based on randomized trials (Tricoci et al., 2009). In part this is due
to continued development of treatments, in part to enormous expense of clinical trials, and in
large part to the hundreds of treatments and their nuances involved in real-world, heterogeneous
clinical practice. Thus, many therapeutic decisions are based on observational studies. However,
comparative treatment effectiveness studies of observational data suffer from two major prob-
lems: only partial overlap of treatments and selection bias. Each treatment is to a degree bounded
within constraints of indication and appropriateness. Thus, transplantation is constrained by vari-
ables such as age, a mitral valve procedure is constrained by presence of mitral valve regurgita-
tion. However, these boundaries overlap widely, and the same patient may be treated differently
by different physicians or different hospitals, often without explicit or evident reasons. Thus,
a fundamental hurdle in observational studies evaluating comparative effectiveness of treatment
options is to address the resulting selection bias or confounding. Naively evaluating differences
in outcomes without doing so leads to biased results and flawed scientific conclusions.
Formally, let {(X1, T1, Y1), . . . , (Xn, Tn, Yn)} denote the data where Xi is the covariate vec-
tor for individual i and Yi is the observed outcome. Here Ti denotes the treatment group of i. For
concreteness, let us say Ti = 0 represents the control group, and Ti = 1 the intervention group.
Our goal is to estimate the individual treatment effect (ITE), defined as the difference in the mean
outcome for an individual under both treatments, conditional on the observed covariates. More
formally, let Yi(0) amd Yi(1) denote the potential outcome for i under treatments Ti = 0 and
Ti = 1, respectively. Given Xi = x, the ITE for i is defined as the conditional mean difference
in potential outcomes
τ(x) = E [Yi(1)|Xi = x]− E [Yi(0)|Xi = x] . (1)
Definition (1) relies on what is called the counterfactual framework, or potential outcomes model
(Neyman et al., 1990; Rubin, 1974). In this framework, one plays the game of hypothesizing
what would have happened if an individual i had received both treatments. However, the dif-
ficulty with estimating (1) is that although potential outcomes {Yi(0), Yi(1)} are hypothesized
to exist, only the outcome Yi from the actual treatment assignment is observed. Without addi-
2
tional assumptions, it is not possible in general to estimate (1). A widely used assumption to
resolve this problem, and one that we adopt, is the assumption of strongly ignorable treatment
assignment (SITA). This assumes that treatment assignment is conditionally independent of the
potential outcomes given the variables; i.e., T ⊥ {Y (0), Y (1)} | X. Under the assumption of
SITA, we have
τ(x) = E [Y (1)|T = 1,X = x]− E [Y (0)|T = 0,X = x]
= E [Y |T = 1,X = x]− E [Y |T = 0,X = x] . (2)
Thus, τ(x) becomes estimable under SITA as it can be expressed in terms of conditional ex-
pectations of observable values. It should be emphasized that without SITA one cannot guar-
antee estimability of τ(x) because E [Y |T = j,X = x] = E [Y (j)|X = x] does not hold in
general. SITA also provides a means for estimating the average treatment effect (ATE), a stan-
dard measure of performance in non-heterogeneous treatment settings. The ATE is defined as
τ0 = E [Yi(1)]− E [Yi(0)] = E [τ(X)]. By averaging over the distribution of X in (2),
τ0 = E
{
E [Y |T = 1,X = x]− E [Y |T = 0,X = x]
}
= E [Y |T = 1]− E [Y |T = 0] . (3)
Thus, SITA also ensures that τ0 is estimable.
Although direct estimation of (2) or (3) is possible by using mean treatment differences in
cells with the same X, due to the curse of dimensionality this method only works when X is low
dimensional. Propensity score analysis (Rosenbaum and Rubin, 1983) is one means to overcome
this problem. The propensity score is defined as the conditional probability of receiving the inter-
vention given X = x, denoted here by e(x) = P{T = 1|X = x}. Under the assumption of SITA,
the propensity score possesses the so-called balancing property. This means that T and X are
conditionally independent given e(X). Thus variables X are balanced between the two treatment
groups after conditioning on the propensity score, thereby approximating a randomized clinical
trial (Rubin, 2007). Importantly, the propensity score is the coarsest possible balancing score,
thus not only does it balance the data, but it does so by using the coarsest possible conditioning,
thus helping to mitigate the curse of dimensionality. In order to use the propensity score for
treatment effect estimation, Rosenbaum and Rubin (1983) further showed that if the propensity
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score is bounded 0 < e(X) < 1 and SITA holds, then treatment assignment is conditionally in-
dependent of the potential outcomes given the propensity score; i.e., T ⊥ {Y (0), Y (1)} | e(X).
This result is the foundation for ATE estimators based on stratification or matching of the data on
propensity scores. However, this is not the only means for using the propensity score to estimate
treatment effect. Another approach is to use SITA to derive weighted estimators for the ATE.
Analogous to (2), under SITA one has
E
[
TY
e(X)
∣∣∣∣X = x] = E [Y |T = 1,X = x] , E [(1− T )Y1− e(X)
∣∣∣∣X = x] = E [Y |T = 0,X = x] ,
which is the basis for ATE weighted propensity score estimators. See for example, Hirano et al.
(2003) and Lunceford and Davidian (2004).
1.1 Individual treatment effect estimation
As mentioned, our focus is on estimating the ITE. Although effectiveness of treatment in ob-
servational studies has traditionally been measured by the ATE, the practice of individualized
medicine, coupled with the increasing complexity of modern studies, have shifted recent efforts
towards a more patient-centric view (Lamont et al., 2016). Accommodating complex individual
characteristics in this new landscape has proven challenging, and for this reason there has been
much interest in leveraging cutting-edge approaches, especially those from machine learning.
Machine learning techniques such as random forests (Breiman, 2001) (RF) provide a principled
approach to explore a large number of predictors and identify replicable sets of predictive factors.
In recent innovations these RF approaches have been used specifically to uncover subgroups with
differential treatment responses (Su et al., 2009, 2011; Foster et al., 2011). Some of these, such
as the virtual twins approach (Foster et al., 2011), build on the idea of counterfactuals. Virtual
twins uses RF as a first step to create separate predictions of outcomes under both treatment and
control conditions for each trial participant by estimating the counterfactual treatment outcome.
In the second step, tree-based predictors are used to uncover variables that explain differences in
the person-specific treatment and the characteristics associated with subgroups. In a different ap-
proach, Wager and Athey (2015) describe causal forests for ITE estimation. Others have sought
to use RF as a first step in propensity score analysis as a means to nonparametrically estimate the
propensity score. Lee et al. (2010) found that RF estimated propensity scores resulted in better
balance and bias reduction than classical logistic regression estimation of propensity scores.
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In this manuscript, we look at several different RF methods for estimating the ITE. A common
thread among these methods is that they all directly estimate the ITE, and each does so without
making use of the propensity score. Although propensity score analyses have traditionally been
used for estimating the ATE, non-ATE estimation generally takes a more direct approach by
modeling the outcome. Typically this is done by using some form of regression modeling. For
example, this is the key idea underlying the widely used “g-formula” algorithm (Robins et al.,
1999). Another example are Bayesian tree methods for regression surface modeling which have
been successfully used to identify causal effects (Hill, 2011). The basis for all of these approaches
rests on the assumption of SITA. Assuming that the outcome Y satisfies
Y = f(X, T ) + ε,
where E(ε) = 0 and f is the unknown regression function, and assuming that SITA holds, we
have
τ(x) = E [Y (1)|T = 1,X = x]− E [Y (0)|T = 0,X = x]
= E [Y |T = 1,X = x]− E [Y |T = 0,X = x]
= f(x, 1)− f(x, 0). (4)
Therefore by modeling f(x, T ), we obtain a means for directly estimating the ITE.
Our proposed RF methods for direct estimation of the ITE are described in Section 2. In
Section 3, we use three sets of challenging simulations to assess performance of these methods.
We find those methods with greatest adaptivity to potential confounding, when combined with
out-of-sample estimation, do best. One particularly promising approach is a counterfactual ap-
proach in which separate forests are constructed using data from each treatment assignment. To
estimate the ITE, each individual’s predicted outcome is obtained from their treatment assigned
forest. Next, the individual’s treatment is replaced with the counterfactual treatment and used to
obtain the counterfactual predicted outcome from the counterfactual forest; the two values are
differenced to obtain the estimated ITE. This is an extension of the virtual twin approach, modi-
fied to allow for greater adaptation to potentially complex treatment responses across individuals.
Furthermore, when combined with synthetic forests (Ishwaran and Malley, 2014), performance
of the method is further enhanced due to reduced bias. In Section 4, we illustrate the new counter-
factual synthetic method on a large comparative effectiveness trial, Project Aware (Metsch et al.,
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2013). An original goal of the project was to determine if risk reduction counseling for HIV
negative individuals at the time of an HIV test had an impact on cumulative incidence of sexually
transmitted infection (STI). However, secondary outcomes included continuous and count out-
comes such as total number of condomless sexual episodes, number of partners, and number of
unprotected sex acts. This trial had a significant subgroup effect in which men who have sex with
men showed a surprising higher rate of STI when receiving risk-reduction counseling. This sub-
group effect makes this trial ideal for looking at heterogeneity of treatment effects in randomized
studies. The trial also had significant heterogeneity by drug use. In particular, substance use is
associated with higher rates of HIV testing, and Black women showing the highest rates of HIV
testing in substance use treatment. Drug use is a modifiable exposure (treatment) variable and
we can therefore use our methods for addressing heterogeneity in observational data to study its
impact on sexual risk. As detailed in Section 4, we show how our methods can be used to exam-
ine whether observed drug use differences are merely proxies for differences on other observed
variables.
2 Methods for estimating individual treatment effects
Here we describe our proposed RF methods for estimating the ITE (1). Also considered are two
comparison methods. The methods considered in this paper are as follows:
1. Virtual twins (VT).
2. Virtual twins interaction (VT-I).
3. Counterfactual RF (CF).
4. Counterfactual synthetic RF (synCF).
5. Bivariate RF (bivariate).
6. Honest RF (honest RF).
7. Bayesian Adaptive Regression Trees (BART).
Virtual twins is the original method proposed by Foster et al. (2011) mentioned earlier. We
also consider an extension of the method, called virtual twins interaction, which includes forced
interactions in the design matrix for more adaptivity. Forcing treatment interactions for adaptivity
may have a limited ceiling, which is why we propose the counterfactual RF method. In this
method we dispense with interactions and instead fit separate forests to each of the treatment
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groups. Counterfactual synthetic RF uses this same idea, but uses synthetic forests in place of
Breiman forests, which is expected to further improve adaptivity. Thus, this method, and the
previous RF methods, are all proposed enhancements to the original virtual twins method. All of
these share the common feature that they provide a direct estimate for the ITE by estimating the
regression surface of the outcome. This is in contrast to our other proposed procedure, bivariate
RF, which takes a missing data approach to the problem. There has been much interest in the
literature in viewing causual effect analysis as a missing data problem (Ghosh et al., 2015). Thus,
we propose here a novel bivariate imputation approach using RF. Finally, the last two methods,
honest RF and BART, are included as comparison procedures. Like our proposed RF methods,
they also directly estimate the ITE. Note that while BART (Chipman et al., 2010) is a tree-based
method, it is not actually a RF method. We include it, however, because of its reported success in
applications to causal inference (Hill, 2011). In the following sections we provide more details
about each of the above methods.
2.1 Virtual twins
Foster et al. (2011) proposed Virtual Twins (VT) for estimating counterfactual outcomes. In this
approach, RF is used to regress Yi against (Xi, Ti). To obtain a counterfactual estimate for an
individual i, one creates a VT data point, similar in all regards to the original data point (Xi, Ti)
for i, but with the observed treatment Ti replaced with the counterfactual treatment 1−Ti. Given
an individual iwith Ti = 1, one obtains the RF predicted value Yˆi(1) by running i’s unaltered data
down the forest. To obtain i’s counterfactual estimate, one runs the altered (Xi, 1−Ti) = (Xi, 0)
down the forest to obtain the counterfactual estimate Yˆi(0). The counterfactual ITE estimate is
defined as Yˆi(1) − Yˆi(0). A similar argument is applied when Ti = 0. If YˆVT(x, T ) denotes the
predicted value for (x, T ) from the VT forest, the VT counterfactual estimate for τ(x) is
τˆVT(x) = YˆVT(x, 1)− YˆVT(x, 0).
As noted in Foster et al. (2011), the VT approach can be improved by manually including treat-
ment interactions in the design matrix. Thus, one runs a RF regression with Yi regressed against
(Xi, Ti,XiTi). The inclusion of the pairwise interactions XiTi is not conceptually necessary for
VT, but Foster et al. (2011) found in numerical work that it improved results. We write τˆVT-I(x)
to denote the ITE estimate under this modified VT interaction model.
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There is an important computational point that we mention here that applies not only to the
above procedure, but also to many of the proposed RF methods. That is when implementing a
RF procedure, we attempt to use out-of-bag (OOB) estimates whenever possible. This is because
OOB estimates are generally much more accurate than insample (inbag) estimates (Breiman,
1996). Because inbag/OOB estimation is not made very clear in the RF literature, it is worth
discussing this point here as readers may be unaware of this important distinction. OOB refers
to out-of-sample (cross-validated) estimates. Each tree in a forest is constructed from a bootstrap
sample which uses approximately 63% of the data. The remaining 37% of the data is called OOB
and are used to calculate an OOB predicted value for a case. The OOB predicted value is defined
as the predicted value for a case using only those trees where the case is OOB. For example, if
1000 trees are grown, approximately 370 will be used in calculating the OOB estimate for the
case. The inbag predicted value, on the other hand, uses all 1000 trees.
To illustrate how OOB estimation applies to VT, suppose that case x is assigned treatment
T = 1. Let Yˆ ∗VT(x, T ) denote the OOB predicted value for (x, T ). The OOB counterfactual
estimate for τ(x) is
τˆVT(x) = Yˆ
∗
VT(x, 1)− YˆVT(x, 0).
Note that YˆVT(x, 0) is not OOB. This is because (x, 0) is a new data point and technically speaking
cannot have an OOB predicted value as the observation is not even in the training data. In a
likewise fashion, if x were assigned treatment T = 0, the OOB estimate is
τˆVT(x) = YˆVT(x, 1)− Yˆ ∗VT(x, 0).
OOB counterfactual estimates for VT interactions, τˆVT-I(x), are defined analogously.
2.2 Counterfactual RF
As mentioned earlier, adding treatment interactions to the design matrix may have a limited
ceiling for adaptivity and thus we introduce the following important extension to τˆVT-I. Rather
than fitting a single forest with forced treatment interactions, we instead fit a separate forest to
each treatment group to allow for greater adaptivity. This modification to VT was mentioned
briefly in the paper by Foster et al. (2011) although not implemented. A related idea was used
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by Dasgupta et al. (2014) to estimate conditional odds ratios by fitting separate RF to different
exposure groups.
In this method, forests CF1 and CF0 are fit separately to data {(Xi, Yi) : Ti = 1} and
{(Xi, Yi) : Ti = 0}, respectively. To obtain a counterfactual ITE estimate, each data point is
run down its natural forest, as well as its counterfactual forest. If YˆCF,j(x, T ) denotes the pre-
dicted value for (x, T ) from CFj , for j = 0, 1, the counterfactual ITE estimate is
τˆCF(x) = YˆCF,1(x, 1)− YˆCF,0(x, 0).
We note that just as with VT estimates, OOB values are utilized whenever possible to improve
stability of estimated values. Thus, if x is assigned treatment T = 1, the OOB ITE estimate is
τˆCF(x) = Yˆ
∗
CF,1(x, 1)− YˆCF,0(x, 0),
where Yˆ ∗CF,1(x, 1) is the OOB predicted value for (x, 1). Likewise, if x is assigned treatment
T = 0, the OOB estimate is
τˆCF(x) = YˆCF,1(x, 1)− Yˆ ∗CF,0(x, 0).
2.3 Counterfactual synthetic RF
In a modification to the above approach, we replace Breiman RF regression used for predicting
YˆCF,j(x, T ) with synthetic forest regression using synthetic forests (Ishwaran and Malley, 2014).
The latter are a new type of forest designed to improve prediction performance of RF. Using
a collection of Breiman forests (called base learners) grown under different tuning parameters,
each generating a predicted value called a synthetic feature, a synthetic forest is defined as a
secondary forest calculated using the new input synthetic features, along with all the original
features. Typically, the base learners used by synthetic forests are Breiman forests grown under
different nodesize and mtry parameters. The latter are tuning parameters used in building a
Breiman forest. In RF, prior to splitting a tree node, a random subset of mtry variables are chosen
from the original variables. Only these randomly selected variables are used for splitting the
node. Splitting is applied recursively and the tree grown as deeply as possible while maintaining
a sample size condition that each terminal node contains a minimum of nodesize cases. The two
tuning parameters mtry and nodesize are fundamental to the performance of RF. Synthetic forests
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exploits this and uses RF base learners grown under different mtry and nodesize parameter values.
To distinguish the proposed synthetic forest method from the counterfactual approach described
above, we use the abbreviation synCF and denote its ITE estimate by τˆsynCF(x):
τˆsynCF(x) = YˆsynCF,1(x, 1)− YˆsynCF,0(x, 0),
where YˆsynCF,j(x, T ) denotes the predicted value for (x, T ) from the synthetic RF grown using
data {(Xi, Ti, Yi) : Ti = j} for j = 0, 1. As before, OOB estimation is used whenever possible.
In particular, bootstrap samples are held fixed throughout when constructing synthetic features
and the synthetic forest calculated from these features. This is done to ensure a coherent definition
of being out-of-sample.
2.4 Bivariate imputation approach
We also introduce a new bivariate approach making use of bivariate RF counterfactuals. For each
individual i, we assume the existence of bivariate outcomes under the two treatment groups. One
of these is the observed Yi under the assigned treatment Ti, the other is the unobserved Yi under
the counterfactual treatment 1 − Ti. This latter value is assumed to be missing. To impute these
missing outcomes a bivariate splitting rule is used (Ishwaran et al., 2008; Tang and Ishwaran,
2015). In the first iteration of the algorithm, the bivariate splitting rule only uses the observed
Yi value when splitting a tree node. At the completion of the forest, the missing Yi values are
imputed by averaging OOB terminal node Y values. This results in a data set without missing
values, which is then used as the input to another bivariate RF regression. In this, the bivariate
splitting rule is applied to the bivariate response values (no missing values are present at this
point). At the completion of the forest, Y values that were originally missing are reset to missing
and imputed using mean terminal node Y values. This results in a data set without missing values,
which is used once again as the input to another bivariate RF regression. This process is repeated
a fixed number of times. At the completion of the algorithm, we have complete bivariate Yi
responses for each i, which we denote by Yˆbivariate,i = (Yˆbivariate,1, Yˆbivariate,0). Note that one of
these values is the original observed (non-missing) response. The complete bivariate values are
used to calculate the bivariate counterfactual estimate
τˆbivariate(x) = Yˆbivariate,1(x)− Yˆbivariate,0(x).
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2.5 Honest RF
As a comparison procedure, we consider the honest RF method described in Procedure 1 of Wa-
ger and Athey (2015). In this method, a RF is run by regressing Yi on (Xi, Ti), but using only a
randomly selected 50% subset of the data. When fitting RF to this training data, a modified re-
gression splitting rule is used. Rather than splitting tree nodes by maximizing the node variance,
honest RF instead uses a splitting rule which maximizes the treatment difference within a node
(see Procedure 1 and Remark 1 in Wager and Athey, 2015). Once the forest is grown, the ter-
minal nodes of the training forest are repopulated by replacing the training Y with the Y values
from the data that was held out. The purpose of this hold out data is to provide honest estimates
and is akin to the role played by the OOB data used in our previous procedures. The difference
between the hold out Y values under the two treatment groups is determined for each terminal
node and averaged over the forest. This forest averaged value represents the honest forest ITE
estimate. We denote the honest RF estimate by τˆhonestRF(x).
2.6 BART
Hill (2011) described a causal inferential approach based on BART (Chipman et al., 2010). The
BART procedure is a type of ensembled backfitting algorithm based on Bayesian regularized
tree learners. Because the algorithm repeatedly refits tree residuals, BART can be intuitively
thought of as a Bayesian regularized tree boosting procedure. Hill (2011) proposed using BART
to directly model the regression surface to estimate potential outcomes. Therefore, this is similar
to VT, but where RF is replaced with BART. The BART ITE estimate is defined as
τˆBART(x) = YˆBART(x, 1)− YˆBART(x, 0)
where YˆBART(x, T ) denotes the predicted value for (x, T ) from BART. Note that due to the highly
adaptive nature of BART, no forced interactions are included in the design matrix.
3 Simulation experiments
Simulation models with differing types of heterogeneous treatment effects were used to assess
performance of the different methods. We simulated p = 20 independent covariates, where
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covariates X1, . . . , X11 were drawn from a standard N(0, 1), and covariates X12, . . . , X20 from a
Bernoulli(0.5). Three different models were used for the outcome Y , while a common simulation
model was used for the treatment variable T ∈ {0, 1}. For the latter, a logistic regression model
was used to simulate T in which the linear predictor F (X) defined on the logit scale was
F (X) = −2 + .028X1 − .374X2 − .03X3 + .118X4 − 0.394X11 + 0.875X12 + 0.9X13.
For the three outcome models, the outcome was assumed to be Yi = fj(Xi, Ti) + εi, where εi
were independent N(0, σ2). The mean functions fj for the three simulations were
f1(X, T ) = 2.455− 1{T=0} × (.4X1 + .154X2 − .152X11 − .126X12)− 1{T=1, g(X)>0}
f2(X, T ) = 2.455− 1{T=0} × sin(.4X1 + .154X2 − .152X11 − .126X12)− 1{T=1, g(X)>0}
f3(X, T ) = 2.455− 1{T=0} × sin(.4X1 + .154X2 − .152X11 − .126X12)− 1{T=1, h(X)>0}
where g(X) = .254X22 − .152X11− .4X211− .126X12 and h(X) = .254X23 − .152X4− .126X5−
.4X25 . Therefore in all three models, X1, X2, X11, X12 were confounding variables, meaning that
they were related to both the treatment and the outcome variable. In model 3, variables X3 and
X4 are additionally confounded. Also, because all three models contain treatment-covariate in-
teractions, all models simulate scenarios of confounded heterogeneous treatment effect (CHTE).
The type of CHTE simulated is different for each model. In model 1, there is a non-linear effect
for treatment T = 1. For model 2, there are non-linear effects for both treatment groups, and
in model 3, non-linear effects are present for both treatment groups, and there is non-overlap in
covariates across treatment groups.
3.1 Experimental settings and parameters
The three simulation models were run under two settings for the sample size, n = 500 and
n = 5000. All simulations used σ = 0.1 for the standard deviation of the measurement errors.
The smaller sample size experiments n = 500 were repeated independently B = 1000 times, the
larger n = 5000 experiments were repeated B = 250 times. All random forests were based on
1000 trees with mtry = p/3 and a nodesize of 3 with the exception of bivariate RF and synthetic
RF. For bivariate forests, a nodesize of 1 was used (following the strategy recommended by Tang
and Ishwaran, 2015), while for for synthetic RF, the RF base learners were constructed using all
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possible combinations of nodesize values 1–10, 20, 30, 50, 100 and mtry values 1, 10 and 20 (for
a total of 42 forest base learners). The bivariate procedure was iterated 5 times (i.e., each run used
a 5 step iteration procedure). All forest computations except for honest RF were implemented
using the randomForestSRC R-package (Ishwaran and Kogalur, 2016) (hereafter abbreviated
as RF-SRC). The RF-SRC package implements all forms of RF data imputation, fits synthetic
forests, multivariate forests, and utilizes openMP parallel processing for rapid computations. For
honest RF, we used the R-package causalForest available at github https://github.
com/swager/causalForest. The nodesize was set to 1 and 1000 trees were used. For
BART, we used the bart function from the R-package BayesTree (Chipman and McCulloch,
2016). A total of 1000 trees were used.
3.2 Performance measures
Performance was assessed by bias and root mean squared error (RMSE). When calculating these
measures we conditioned on the propensity score, e(x). This was done to assess how well a
procedure could recover treatment heterogeneity effects and to provide insight into its sensitivity
to treatment assignment. A robust procedure should perform well not only in regions of the
data where e(x) = 0.5, and treatment assignment is balanced, but also in those regions where
treatment assignment is unbalanced, 0 < e(x) < .5 and 1 > e(x) > .5. Assume the data
is stratified into groups G = {G1, . . . ,GM} based on quantiles q1, . . . , qM of e(x). Given an
estimator τˆ of τ , the bias for group Gm was defined as
Bias(m) = E
[
τˆ(X)|X ∈ Gm
]
− E
[
τ(X)|X ∈ Gm
]
, m = 1, . . . ,M.
Recall that our simulation experiments were replicated independently B times. Let Gm,b denote
those x values that lie within the qm quantile of the propensity score from realization b. Let τˆb be
the ITE estimator from realization b. The conditional bias was estimated by
B̂ias(m) =
1
B
B∑
b=1
τˆm,b − 1
B
B∑
b=1
τm,b
where
τˆm,b =
1
#Gm,b
∑
xi∈Gm,b
τˆb(xi), τm,b =
1
#Gm,b
∑
xi∈Gm,b
τ(xi).
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Similarly, we define the conditional RMSE of τˆ by
RMSE(m) =
√
E
[(
τˆ(X)− τ(X)
)2 ∣∣∣∣X ∈ Gm], m = 1, . . . ,M,
which we estimated using
R̂MSE(m) =
√√√√ 1
B
B∑
b=1
1
#Gm,b
∑
xi∈Gm,b
[
τˆb(xi)− τb(xi)
]2
.
3.3 Results
Figure 1 displays the conditional bias and RMSE for each method for each of the simulation
experiments. Light and dark boxplots display results for the small and larger sample sizes, n =
500 and n = 5000; the left and right panels display bias and RMSE, respectively. Each boxplot
displays M values for the performance measure evaluated at each of the M stratified propensity
score groups. We used a value of M = 100 throughout.
Considering the RMSE results (right panels), it is clear that counterfactual synthetic forests,
τˆsynCF, is generally the best of all procedures, with results improving with increasing n. The
BART procedure, τˆBART, is comparable or slightly better in simulations 1 and 2 when n = 500,
but τˆsynCF dominates when the sample size increases to n = 5000. In simulation 3, τˆsynCF is
superior regardless of sample size. It is interesting to observe that counterfactual forests, τˆCF,
which do not use synthetic forests for prediction, is systematically worse than τˆsynCF. In fact,
its performance is generally about the same as τˆVT-I and the same as τˆBART when n = 5000.
Regarding τˆVT-I, it is interesting to observe how it systematically outperforms τˆVT regardless of
simulation or sample size. This shows that augmenting the design matrix to include treatment
interactions really improves adaptivity of VT forests. Finally, the least successful procedure
(for the large sample size simulations) was the bivariate imputation method, τˆbivariate. Recall
that the bivariate procedure differs from the other procedures in that it uses mean imputation
rather than regression modeling of the outcome for ITE estimation. This may explain its poorer
performance. Following τˆbivariate in terms of overall performance, are τˆVT and τˆhonestRF, with
τˆhonestRF somewhere in between τˆVT and τˆVT-I. This completes the discussion of the RMSE. The
results for bias (left panels) generally mirror those for RMSE. One interesting finding, however,
is the tightness of the range of bias values for τˆsynCF when n = 5000. This shows that with
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Figure 1: Bias and RMSE results from simulation experiments.
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increasing sample size, τˆsynCF gives consistently low bias even across extreme propensity score
values.
4 Project Aware: a counterfactual approach to understanding
the role of drug use in sexual risk
Project Aware was a randomized clinical trial performed in nine sexually transmitted disease
clinics in the United States. The primary aim was to test whether brief risk-reduction counseling
performed at the time of an HIV test had any impact on subsequent incidence of sexually trans-
mitted infections (STIs). The results showed no impact of risk-reduction counseling on STIs.
Neither were there any substance use interactions of the impact of risk-reduction counseling;
however, substance use was associated with higher levels of STIs at follow-up. Other research
has shown that substance use is associated with higher rates of HIV testing, and Black women
showing the highest rates of HIV testing in substance use treatment clinics (Herna´ndez et al.,
2016). Since substance use is associated with risky sexual activity, detecting the dynamics of this
relationship can contribute to preventive and educational efforts to control the spread of HIV. Our
procedures for causal analysis of heterogeneity of effects in observational data should equalize
the observed characteristics among substance use and non-substance use participants, thereby
removing any impact of background imbalance in factors that may be related to relationship of
substance use on sexual risk. Our procedure then allows an exploration of background factors
that are truly related to this causal effect, conditional on all confounding factors being in the
feature set.
To explore this issue of how substance use plays a role in sexual risk, we pursued an analysis
in which the treatment (exposure) variable T was defined as drug use status of an individual (0
= no substance use in the prior 6 months, 1 = any substance use in the prior 6 months leading to
the study). For our outcome, we used number of unprotected sex acts within the last six months
as reported by the individual. Although Project Aware was randomized on the primary outcome
(risk-reduction counseling), analysis of secondary outcomes such as substance use should be
treated as if from an observational study. Indeed, unbalancedness of the data for drug use can be
gleaned from Table 1 which displays results from a logistic regression in which drug use status
16
was used for the dependent variable (n = 2813, p = 99). The list of significant variables suggests
the data is unbalanced and indicates that inferential methods should be considered carefully. Thus
Table 2, which displays the results from a linear regression using number of unprotected sex acts
as the dependent variable, should be interpreted with caution. Table 2 suggests there is no overall
exposure effect of drug use, although several variables have significant drug-interactions.
Table 1: Difference in variables by drug use illustrating unbalancedness of Aware data. Only
significant variables (p-value < 0.05) from logistic regression analysis are displayed for clarity.
Estimate Std. Error Z p-value
Race -0.28 0.11 -2.50 0.01
Chlamydia 0.34 0.15 2.30 0.02
Site 2 -0.62 0.16 -3.94 0.00
Site 4 -0.53 0.16 -3.23 0.00
Site 6 0.44 0.18 2.43 0.01
Site 7 -0.65 0.15 -4.22 0.00
Site 8 0.95 0.21 4.51 0.00
HIV risk 0.17 0.03 5.14 0.00
CESD 0.02 0.01 3.13 0.00
Condom change 2 -0.24 0.12 -2.07 0.04
Marriage 0.08 0.03 2.76 0.01
In Jail ever 0.42 0.10 4.07 0.00
AA/NA last 6 months 1 0.69 0.23 3.04 0.00
Frequency of injection 0.18 0.07 2.49 0.01
Gender -0.39 0.10 -4.00 0.00
However, in order to avoid drawing potentially flawed conclusions from an analysis like Ta-
ble 2, we applied our counterfactual synthetic approach, τˆsynCF. A synthetic forest was fit sepa-
rately to each exposure group using number of unprotected sex acts as the dependent variable.
This yielded estimated causal effects {τˆsynCF(xi), i = 1, . . . , n} for τ(x) defined as the mean dif-
ference in number of unprotected sex acts for drug versus non-drug users. The estimated causal
effects were then used as dependent variables in a linear regression analysis. This is convenient
because the estimated coefficients from the regression analysis can be interpreted in terms of
subgroup causal differences (we elaborate on this point shortly). In order to derive valid standard
errors and confidence regions for the estimated coefficients, the entire procedure was subsampled.
That is, we drew a sample of sizemwithout replacement. The subsampled data was then fit using
synthetic forests as described above, and the resulting estimated causal effects used as the depen-
17
Table 2: Linear regression where dependent variable is number of unprotected sex acts from
Aware data. Only variables with p-value < 0.10 from regression analysis are displayed for
clarity.
Estimate Std. Error Z p-value
Intercept -5.06 22.17 -0.23 0.82
Drug 9.59 29.72 0.32 0.75
HCV2 8.14 4.09 1.99 0.05
Site 2 -14.00 6.82 -2.05 0.04
HIV risk 3.89 1.41 2.76 0.01
Condom change 3 -17.23 6.52 -2.64 0.01
Condom change 5 -21.98 6.65 -3.30 0.00
Visit opthamologist -16.46 8.17 -2.01 0.04
Number visit opthamologist 9.13 3.93 2.33 0.02
Marriage -2.13 1.17 -1.81 0.07
Smoke 53.13 16.26 3.27 0.00
Number cigarette per day -14.63 4.76 -3.07 0.00
Drug x CESD 0.88 0.47 1.88 0.06
Drug x Condom change 2 -24.70 6.83 -3.62 0.00
Drug x Condom change 3 -25.82 8.75 -2.95 0.00
Drug x Condom change 4 -37.58 14.20 -2.65 0.01
Drug x Condom change 5 -28.78 9.33 -3.08 0.00
Drug x Visit dentist -16.36 8.26 -1.98 0.05
Drug x Smoke -34.71 20.53 -1.69 0.09
Drug x Number cigarette per day 9.81 5.95 1.65 0.10
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dent variable in a linear regression. The procedure was repeated 1000 times independently. A
subsampling size of m = n/10 was used. The confidence regions of the resulting coefficients are
displayed in Figure 2. Table 3 displays the coefficients for significant values (p-values< .05). We
note that bootstrapping could have have been used as another means to generate nonparametric
p-values and confidence regions. However, we prefer subsampling because of its computational
speed and general robustness (Politis et al., 1999).
To interpret the coefficients in Table 3, it is useful to write the true model for the outcome
(number of unprotected sex acts) as Y = f(X, T ) + ε, where
f(X, T ) = α0T + h(X, T ),
and h is some unknown function. Under the assumption of SITA, and using the same calculations
as (4), we have
τ(x) = f(x, 1)− f(x, 0) = α0 + h(x, 1)− h(x, 0).
Now since we assume a linear model α +
∑p
j=1 βjxj for the ITE, we have
α0 + h(x, 1)− h(x, 0) = α +
p∑
j=1
βjxj.
From this we can infer that the intercept in Table 3 is an overall measure of the exposure effect
of drug use, α0 (this is why the intercept term is listed as drug use). Here the estimated coeffi-
cient is 17.0. The positive coefficient implies that on average drug users have significantly more
unprotected sex acts than non-drug users (significance here is slightly larger than 5%).
The remaining coefficients in Table 3 describe how the effect of drug use on sexual risk is
modulated by other factors. Under our linear model, we have
h(x, 1)− h(x, 0) =
p∑
j=1
βjxj.
Because h(x, 1)−h(x, 0) represents how much a subgroup deviates from the overall causal effect,
each coefficient in Table 3 quantifies the effect of a specific subgroup on drug use differences.
Consider for example, the variable “Frequency of injection” which is a continuous variable repre-
senting frequency of injections in drug users. Because its estimated coefficient is 3.6, this means
the difference in unprotected sex acts between drug and and non-drug users, which is positive,
19
Figure 2: Confidence intervals for all coefficients of linear model used in Table 3. Intervals
determined using subsampling. Dark colored boxplots indicate variables with p-value < .05.
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Table 3: Linear regression of Aware data with dependent variable equal to the estimated causal
effects {τˆsynCF(xi), i = 1, . . . , n} from counterfactual synthetic random forests. Causal effect
is defined as the mean difference in unprotected sex acts for drug users versus non-drug users.
Standard errors and significance of linear model coefficients were determined using subsampling.
For clarity, only significant variables with p-value < 0.05 are displayed (the intercept is provided
for reference but is not significant).
Estimate Std. Error Z
Intercept (drug use) 16.97 9.36 1.81
CESD 0.60 0.13 4.54
Condom change 2 -19.38 2.96 -6.56
Condom change 3 -23.33 3.23 -7.22
Condom change 4 -21.46 3.39 -6.32
Condom change 5 -24.02 3.41 -7.04
Usual care 3 4.91 2.11 2.33
Marriage -1.61 0.73 -2.21
No health insurance 2.72 0.99 2.75
SU treatment last 6 months 2 6.38 3.20 2.00
Frequency of injection 3.59 1.77 2.02
becomes even wider for high frequency drug users. Another risky factor is “No health insurance”,
which is an indicator of lack of health insurance coverage. Because its estimated coefficient is
2.7, we can take this to mean that the increase in sexual risk for an individual without health in-
surance is more pronounced in drug users. As another example, consider the variable “Condom
change” which is an ordinal categorical variable measuring an individual’s stage of change with
respect to condom use behavior. The baseline level is a “precontemplator”, who is an individ-
ual who has not envisioned using condoms. The second level “contemplator” is an individual
contemplating using condoms. Further increasing levels measure even more willingness to uti-
lize condoms. All coefficients for Condom change in Table 3 are negative, and therefore if an
individual is more willing to utilize safe condom practice (relative to the baseline condition), the
difference in number of unprotected sex acts diminishes between drug and non-drug users. Other
variables that have a subgroup effect are Marriage (whether an individual is married), CESD
(Center for Epidemiological Studies Depression Scale), and SU treatment last 6 months (sub-
stance abuse treatment in last 6 months). In all of these, the pattern is similar to before. With
more risky behavior (with depression) the number of unprotected sex acts increases for non-drug
users relative to drug users, but as risky behavior decreases (e.g. married), the effect of drug use
21
diminishes.
Figure 3 displays a coplot of the RF estimated causal effects {τˆsynCF(xi), i = 1, . . . , n} as a
function of several variables. The coplot is another useful tool that can be used to explore causal
relationships. We use it to uncover relationships that may be hidden in the linear regression
analysis. The RF causal effects are plotted against CESD depression for individuals with and
without health insurance. Conditioning is on the variables Condom change (vertical conditioning)
and HIV risk (horizontal conditioning). HIV risk a self-rated variable and of potential importance
and was included even though it was not significant in the linear regression analysis. For patients
with potential to change condom use (rows 2 through 5), increased depression levels leads to an
increased causal effect of drug use, which is slightly accentuated for high HIV risk (plots going
from left to right). The effect of health insurance is however minimal. On the other hand, for
individuals with low potential to change condom use (bottom row), the estimated exposure effect
is generally high, regardless of depression, but is reduced if the individual has health insurance.
5 Discussion
In observational data with complex heterogeneity of treatment effect, individual estimates of
treatment effect can be obtained in a principled way by directly modeling the response outcome.
However, successful estimation mandates highly adaptive and accurate regression methodology
and for this we relied on RF, a machine learning method with well known properties for ac-
curate estimation in complex nonparametric regression settings. However, care must be used
when applying RF for casual inference. We encourage the use of out-of-bag estimation, a simple
but underappreciated out-of-sample technique for improving accuracy. We also recommend that
when selecting a RF approach, that it should have some means for encouraging adaptivity to con-
founding, i.e. that it can accurately model potentially separate regression surfaces for each of the
treatment groups. One example of this is the extension to VT, which expands the design matrix
to include all pairwise interactions of variables with the treatment, a method we call τˆVT-I, and
described in the paper by Foster et al. (2011). We found that this simple extension, when cou-
pled with out-of-bagging, significantly improved performance of VT. Another promising method
was counterfactual synthetic forests τˆsynCF, which generally had the best performance among all
methods, and was superior in the larger sample size simulations, outperforming even the highly
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Figure 3: RF estimated causal effect of drug use plotted against CESD depression for individ-
uals with and without health insurance. Values are conditioned on Condom change (vertical
conditional axis) and HIV risk (horizontal conditional axis).
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adaptive BART method. The larger sample size requirement is not so surprising as having to
grow separate forests causes some loss of efficiency; this being however mitigated by its superior
bias properties which take hold with increasing n.
In looking back, we can now see that the success of counterfactual synthetic RF can be at-
tributed to three separate effects: (a) fitting separate forests to each treatment group, which im-
proves adaptivity to confounding; (b) replacing Breiman forests with synthetic forests, which
reduces bias; and (c) utilizing OOB estimation, which improves accuracy. Computationally,
counterfactual synthetic RF are easily implemented with available software and have the added
attraction that they reduce parameter tuning. The latter is a consequence and advantage of using
synthetic forests. A synthetic forest is constructed using RF base learners, each of these being
constructed under different nodesize and mtry tuning parameters. Correctly specifying mtry and
nodesize is important for good performance in Breiman forests. The optimal value will depend
on whether the setting is large n, large p, or large p and large n. With synthetic forests this
problem is alleviated by building RF base learners under different tuning parameter values.
Importantly, and underlying all of this, is the potential outcomes model, a powerful hypo-
thetical approach to causation. The challenge is being able to properly fit the potential outcomes
model and for this, as discussed above, we relied on the sophisticated machinery of RF. We em-
phasize that the direct approach of the potential outcomes model is well suited for personalized
inference via the ITE. Estimated ITE values from RF can be readily analyzed using standard re-
gression models to yield direct inferential statements for not only overall treatment effect, but also
interactions, thus facilitating inference beyond the traditional ATE population-centric viewpoint.
Using the Aware data we showed how counterfactual ITE estimates from counterfactual synthetic
forests could be explored to understand causal relations. This revealed interesting connections
between risky behavior, drug use, and sexual risk. The analysis corrects for any observed differ-
ences by the exposure variable, so to the extent that we have observed the important confounding
variables, this result can tentatively be considered causal, though caution should be used due to
this assumption. Clearly, this type of analysis, which controls for observed confounding gives
additional and important insights above simple observed drug usage differences. We also note
that although we used linear regression for interpretation in this analysis, it is possible to utilize
other methods as well. The counterfactual synthetic forest procedure provides a pipleline that
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can be connected with many types of analyses, such as the conditional plots that were also used
in the Aware data analysis.
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